Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry

This study is currently recruiting participants.
Verified June 2012 by New York University School of Medicine
Sponsor:
Information provided by (Responsible Party):
Rany Condos, MD, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00212511
First received: September 13, 2005
Last updated: June 20, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to create a database of demographics and samples in idiopathic pulmonary fibrosis.


Condition
Idiopathic Pulmonary Fibrosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Evaluation of Patients With Idiopathic Pulmonary Fibrosis Through an IPF Registry

Resource links provided by NLM:


Further study details as provided by New York University School of Medicine:

Estimated Enrollment: 50
Study Start Date: November 2004
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with interstitial lung disease.

Criteria

Inclusion Criteria:

  • IPF diagnosis by ATJ criteria or by tissue biopsy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00212511

Contacts
Contact: Rany Condos, MD (212)263-7951 Rany.Condos@nyumc.org

Locations
United States, New York
NYU School of Medicine Recruiting
New York, New York, United States, 10016
Contact: Sue Chow    212-263-6411      
Principal Investigator: Rany Condos, MD         
Sponsors and Collaborators
New York University School of Medicine
Investigators
Principal Investigator: Rany Condos, MD NYU School of Medicine, Division of Pulmonary and Critical Care Medicine
  More Information

No publications provided

Responsible Party: Rany Condos, MD, Assistant Professor of Medicine, New York University School of Medicine
ClinicalTrials.gov Identifier: NCT00212511     History of Changes
Other Study ID Numbers: 10386-02 A
Study First Received: September 13, 2005
Last Updated: June 20, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Fibrosis
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Pathologic Processes
Lung Diseases
Respiratory Tract Diseases
Idiopathic Interstitial Pneumonias
Lung Diseases, Interstitial

ClinicalTrials.gov processed this record on April 15, 2014